期刊文献+

乳腺癌患者癌组织、血清miR-17-5p水平变化及意义 被引量:5

下载PDF
导出
摘要 目的观察乳腺癌患者癌组织、血清miR-17-5p水平变化、分析其临床意义。方法乳腺癌患者30例,分别取其癌组织及相应癌旁组织;另选乳腺癌患者60例、健康女性体检者50例,分别取其外周血。采用实时荧光定量PCR法检测乳腺癌组织及血清中的miR-17-5p。结果乳腺癌组织miR-17-5p表达低于癌旁组织,乳腺癌患者血清miR-17-5p低于健康女性体检者,P均<0.05。结论乳腺癌患者癌组织、血清miR-17-5p均降低,其水平检测有助于乳腺癌的诊断。
作者 魏倩 张鹏
出处 《山东医药》 CAS 北大核心 2015年第16期54-55,共2页 Shandong Medical Journal
  • 相关文献

参考文献13

  • 1Hossain MM,Tesfaye D,Salilew-Wondim D,et al.Massive deregulation of miRNAs from nuclear reprogramming errors during trophoblast differentiation for placentogenesis in cloned pregnancy. BMC Genetics . 2014 被引量:1
  • 2Ping?Yu Wang,Hai?Tao Gong,Bao?Feng Li,Chun?Lei Lv,Huan?Tai Wang,Hui?Hui Zhou,Xin?Xin Li,Shu?Yang Xie,Bao?Fa Jiang.Higher expression of circulating miR?182 as a novel biomarker for breastcancer[J]. Oncology Letters . 2013 (6) 被引量:1
  • 3Mogilyansky E,Rigoutsos I.The miR-17/92cluster: a comprehensive update on itsgenomics, genetics, functions and increasingly important and numerous roles in healthand disease. Cell Death and Differentiation . 2013 被引量:1
  • 4Corinna Eichelser,Dieter Flesch-Janys,Jenny Chang-Claude,Klaus Pantel,Heidi Schwarzenbach.Deregulated Serum Concentrations of Circulating Cell–Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression[J]. Clinical Chemistry . 2013 (10) 被引量:1
  • 5Leigh-Ann MacFarlane,Paul R. Murphy.MicroRNA: Biogenesis, Function and Role in Cancer. Current Genomics . 2010 被引量:2
  • 6Farazi Thalia A,Hoell Jessica I,Morozov Pavel,Tuschl Thomas.MicroRNAs in Human Cancer. Advances in experimental medicine and biology . 2013 被引量:1
  • 7Zhao FL,Dou YC,Wang XF,et al.Serum microRNA-195 is down-regulated in breast cancer:a potential marker for the diagnosis of breast cancer. Molecular Biology Reports . 2014 被引量:1
  • 8Mestdagh P,Hartmann N,Baeriswyl L,et al.Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC)study. Nat Methods . 2014 被引量:1
  • 9Yu Zuoren,Wang Chenguang,Wang Min,Li Zhiping,Casimiro Mathew C,Liu Manran,Wu Kongming,Whittle James,Ju Xiaoming,Hyslop Terry,McCue Peter,Pestell Richard G.A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. Journal of Communication . 2008 被引量:1
  • 10Yu Zuoren,Willmarth Nicole E,Zhou Jie,Katiyar Sanjay,Wang Min,Liu Yang,McCue Peter A,Quong Andrew A,Lisanti Michael P,Pestell Richard G.microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proceedings of the National Academy of Sciences of the United States of America . 2010 被引量:1

二级参考文献22

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262. 被引量:1
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86. 被引量:1
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184. 被引量:1
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962. 被引量:1
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269. 被引量:1
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866. 被引量:1
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179. 被引量:1
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9. 被引量:1
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12. 被引量:1
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261. 被引量:1

共引文献1019

同被引文献34

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部